Atlas Trials

A Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab

Clinical trial NCT05660122 · COMPLETED

Trial details

NCT number
NCT05660122
Sponsor
Daewoong Pharmaceutical Co. LTD.
Status
COMPLETED
Study type
OBSERVATIONAL
Gastroesophageal Reflux Disease
Start date
2022-11-11
Primary completion
2024-12-26
Enrollment
2852

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.